Get the Daily Brief
Latest Biotech News
Novel AI Platforms and Machine Learning Models Enhance Cancer Prognosis and Drug Discovery
Innovations in artificial intelligence are transforming oncology diagnostics and drug discovery. Imagene AI secured $23 million in Series B funding to advance multimodal digital pathology models...
Breakthrough in Glioblastoma Targeting Molecular Motors Improves Treatment Response
Researchers at the Herbert Wertheim UF Scripps Institute unveiled MT-125, a novel drug targeting non-muscle myosin IIA and IIB, that sensitizes glioblastoma tumors to radiation and kinase...
Advances in Parkinson’s Disease Diagnostics and Therapeutics Driven by Machine Learning and Brain Stimulation
A series of studies highlight pivotal shifts in Parkinson’s disease research and treatment. Machine learning models have been developed to track levodopa’s acute effects via digital speech...
Emerging Immunotherapies and Molecular Targets in Cancer Treatment
Recent breakthroughs showcase innovative immunotherapy approaches and target identifications in oncology. ARX788 combined with pyrotinib outperformed standard regimens in HER2+ breast cancer,...
Regulatory and Market Dynamics Impacting Biotech Sector Financing and Operations
The biotech industry faces significant operational challenges as Apple Tree Partners engages in litigation with its main investor, citing funding failures threatening portfolio startups' survival....
AbbVie Buys In Vivo CAR-T Biotech for $2.1 Billion
AbbVie has announced the acquisition of Capstan Therapeutics for up to $2.1 billion in cash, marking a significant expansion into in vivo CAR-T therapies. Capstan’s lead candidate, CPTX2309, a...
Psychedelic Drug Shows Promise, Spurs Biotech Merger Plans
Mid-stage trial data from Beckley Psytech’s intranasal psychedelic compound BPL-003 demonstrated significant symptom reduction in treatment-resistant depression, outperforming a low-dose...
New AI Advances Precision Oncology and Drug Discovery
Innovations in artificial intelligence are driving breakthroughs in cancer diagnostics, drug discovery, and clinical trial optimization. Imagene AI secured $23 million in Series B funding to...
Moderna’s mRNA Flu Vaccine Outperforms Licensed Comparator, FDA Talks Loom
Moderna announced positive Phase 3 results for its mRNA-1010 seasonal influenza vaccine, demonstrating a 26.6% relative vaccine efficacy over a standard-dose marketed influenza shot in adults aged...
New Insights into Chemotherapy’s Genetic Impact on Healthy Blood Cells
A comprehensive study led by the Wellcome Sanger Institute and University of Cambridge systematically examined the somatic genetic effects of chemotherapy on normal blood cells. Using whole-genome...
Breakthrough in Targeting Hard-to-Treat Breast Cancers
Researchers have highlighted the role of circular RNA circLIMK1-005 in promoting lung adenocarcinoma progression via interaction with the RPA1-CDK4 pathway, offering a promising molecular target....
Gut Microbiota and Metabolites Linked to Neurological Disorders
Groundbreaking studies have unveiled novel connections between the gut microbiome and neurological diseases. One investigation reveals that alterations in gut-derived metabolites are associated...
Biotech Venture Funding and Market Movements Shape Industry Landscape
Catalio Capital Management has closed its $400 million Nexus Fund IV to invest in novel healthcare innovations amid a challenging buyer’s market in biotech. The fund supports new company launches...
Precision Medicine Advances with Machine Learning and Genomics Integration
Significant progress is being made in leveraging machine learning and genomic data to improve disease prediction and treatment personalization. Novel algorithms predict breast cancer incidence...
Regulatory and Industry Movements in Healthcare and Biotech
Recent regulatory actions and industry developments include the FDA maintaining a broad definition of cybersecurity devices in its latest guidance and Hong Kong establishing the Centre for Medical...
Psychedelic drug phase 2 success spurs Atai and Beckley merger plans
Atai Life Sciences and Beckley Psytech revealed positive Phase 2b results for intranasal mebufotenin in treatment-resistant depression, significantly reducing symptoms compared to low-dose...
AbbVie to acquire Capstan Therapeutics for $2.1 billion, boosting in vivo CAR-T pipeline
AbbVie secured a $2.1 billion acquisition of Capstan Therapeutics, gaining access to its early-phase in vivo CAR-T platform targeting autoimmune and cancer indications. The purchase follows...
Moderna’s mRNA flu vaccine beats approved comparator, sets up FDA submission
Moderna announced that its mRNA-based seasonal influenza vaccine, mRNA-1010, demonstrated a 26.6% relative vaccine efficacy over a licensed standard-dose flu vaccine in adults aged 50 and older...
CRISPR technology advances with web tools and new activation methods
Recent developments in CRISPR genome editing include novel web-based tools that improve off-target prediction by integrating individual genetic variations, enhancing precision in gene editing...
Pharmacogenomics trial in Scotland tests utility across 60 medications
A pharmacogenomics trial initiated in Scotland is recruiting up to 4,000 patients to evaluate the clinical utility of preemptive genetic testing across 60 medications. The study, conducted in...